• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

身高与乳腺癌患病率呈正相关:一项对德国 135741 名女性的回顾性研究。

Positive association between body height and breast cancer prevalence: a retrospective study with 135,741 women in Germany.

机构信息

Department of Gynecology and Obstetrics, University Hospital Marburg, Philipps-University Marburg, Baldingerstraße, 35043, Marburg, Germany.

Epidemiology, IQVIA, Frankfurt, Germany.

出版信息

Breast Cancer Res Treat. 2022 Nov;196(2):349-354. doi: 10.1007/s10549-022-06730-0. Epub 2022 Sep 10.

DOI:10.1007/s10549-022-06730-0
PMID:36085535
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9581809/
Abstract

PURPOSE

The aim of this study was to analyze the prevalence of breast cancer in relation to body height and to investigate associations between body height and breast cancer in Germany.

METHODS

This retrospective cohort study included 135,741 adult women followed in one of 161 gynecology practices in Germany between January 2019 and December 2021. The 3 year prevalence of breast cancer (ICD-10: C50) during the study period was shown in relation to body height, which was included in this study as a five-category variable for women: ≤ 160 cm, 161-165 cm, 166-170 cm, 171-175 cm, > 175 cm. The associations between height and breast cancer were analyzed using logistic regression models adjusted for age and BMI.

RESULTS

The prevalence of breast cancer increased from 5.1% in women ≤ 160 cm to 6.8% in women > 175 cm in the age group 51-60, and from 9.2% in women ≤ 160 cm to 12.2% in women 171-175 cm in the age group > 60 years. The OR for breast cancer was 1.18 (95% CI 1.12-1.24) for every 10 cm increase in height. Compared to height ≤ 160 cm, the OR for height 166-170 cm was 1.26 (1.15-1.39), for 171-175 cm 1.43 (1.27-1.61), and for > 175 cm 1.49 (1.28-1.74).

CONCLUSION

The results of this study suggest that greater body height in women is significantly related to an increased breast cancer risk.

摘要

目的

本研究旨在分析身高与乳腺癌之间的相关性,并探讨德国身高与乳腺癌之间的关联。

方法

本回顾性队列研究纳入了 2019 年 1 月至 2021 年 12 月期间在德国 161 家妇科诊所就诊的 135741 名成年女性。研究期间,展示了(ICD-10:C50)乳腺癌的 3 年患病率与身高的关系,身高在本研究中作为女性的五个类别变量进行了纳入:≤160cm、161-165cm、166-170cm、171-175cm、>175cm。使用调整年龄和 BMI 的 logistic 回归模型分析身高与乳腺癌之间的关联。

结果

在 51-60 岁年龄组中,身高≤160cm 的女性乳腺癌患病率从 5.1%上升至身高>175cm 的女性的 6.8%,而在>60 岁年龄组中,身高≤160cm 的女性乳腺癌患病率从 9.2%上升至身高 171-175cm 的女性的 12.2%。身高每增加 10cm,乳腺癌的 OR 为 1.18(95%CI 1.12-1.24)。与身高≤160cm 相比,身高 166-170cm 的 OR 为 1.26(1.15-1.39),身高 171-175cm 的 OR 为 1.43(1.27-1.61),身高>175cm 的 OR 为 1.49(1.28-1.74)。

结论

本研究结果表明,女性的身高越高,患乳腺癌的风险显著增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e60e/9581809/e3408f3d7d1b/10549_2022_6730_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e60e/9581809/e3408f3d7d1b/10549_2022_6730_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e60e/9581809/e3408f3d7d1b/10549_2022_6730_Fig1_HTML.jpg

相似文献

1
Positive association between body height and breast cancer prevalence: a retrospective study with 135,741 women in Germany.身高与乳腺癌患病率呈正相关:一项对德国 135741 名女性的回顾性研究。
Breast Cancer Res Treat. 2022 Nov;196(2):349-354. doi: 10.1007/s10549-022-06730-0. Epub 2022 Sep 10.
2
The association between body height and cancer: a retrospective analysis of 784,192 outpatients in Germany.身高与癌症的关联:德国 784192 名门诊患者的回顾性分析。
J Cancer Res Clin Oncol. 2023 Jul;149(8):4275-4282. doi: 10.1007/s00432-022-04335-0. Epub 2022 Sep 6.
3
Height, weight weight change, and postmenopausal breast cancer risk: The Netherlands Cohort Study.身高、体重变化与绝经后乳腺癌风险:荷兰队列研究。
Cancer Causes Control. 1997 Jan;8(1):39-47. doi: 10.1023/a:1018479020716.
4
Birth weight, childhood body mass index, and height in relation to mammographic density and breast cancer: a register-based cohort study.出生体重、儿童期体重指数和身高与乳腺X线密度及乳腺癌的关系:一项基于登记处的队列研究。
Breast Cancer Res. 2014 Jan 20;16(1):R4. doi: 10.1186/bcr3596.
5
Prospective study of height, body mass index and risk of breast cancer.
Acta Oncol. 1992;31(2):195-200. doi: 10.3109/02841869209088902.
6
Anthropometric predictors of breast cancer incidence and survival in a multi-ethnic cohort of female residents of Hawaii, United States.美国夏威夷女性居民多民族队列中乳腺癌发病率和生存率的人体测量学预测指标
Cancer Causes Control. 1998 Mar;9(2):217-24. doi: 10.1023/a:1008842613331.
7
Association of body size and fat distribution with risk of breast cancer among Chinese women.中国女性的体型和脂肪分布与乳腺癌风险的关联
Int J Cancer. 2001 Nov 1;94(3):449-55. doi: 10.1002/ijc.1487.
8
Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC).体型与乳腺癌风险:欧洲癌症与营养前瞻性调查(EPIC)的研究结果
Int J Cancer. 2004 Sep 20;111(5):762-71. doi: 10.1002/ijc.20315.
9
Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk.关于身高、体重与乳腺癌风险的前瞻性队列研究的汇总分析。
Am J Epidemiol. 2000 Sep 15;152(6):514-27. doi: 10.1093/aje/152.6.514.
10
Risk Factors for Breast Cancer, Overall and by Tumor Subtype, among Women from Mozambique, Sub-Saharan Africa.莫桑比克撒哈拉以南非洲女性乳腺癌的总体及肿瘤亚型风险因素。
Cancer Epidemiol Biomarkers Prev. 2021 Jun;30(6):1250-1259. doi: 10.1158/1055-9965.EPI-20-1730. Epub 2021 Apr 13.

引用本文的文献

1
Genetic analysis reveals the shared genetic architecture between breast cancer and atrial fibrillation.基因分析揭示了乳腺癌和心房颤动之间共享的遗传结构。
Front Genet. 2025 Mar 25;16:1450259. doi: 10.3389/fgene.2025.1450259. eCollection 2025.
2
The Role of HMGA1 and Height in Breast Cancer Risk and Prognosis: Insights from UK Biobank Data.HMGA1与身高在乳腺癌风险和预后中的作用:来自英国生物银行数据的见解
Cancer Diagn Progn. 2025 Mar 3;5(2):146-152. doi: 10.21873/cdp.10424. eCollection 2025 Mar-Apr.
3
Mammographic density as a predictor of invasive breast cancer and ductal carcinoma in situ in over six million South Korean women.

本文引用的文献

1
Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review.乳腺癌——流行病学、危险因素、分类、预后标志物及当前治疗策略——最新综述
Cancers (Basel). 2021 Aug 25;13(17):4287. doi: 10.3390/cancers13174287.
2
Obesity and Breast Cancer: A Paradoxical and Controversial Relationship Influenced by Menopausal Status.肥胖与乳腺癌:一种受绝经状态影响的矛盾且具争议性的关系。
Front Oncol. 2021 Aug 13;11:705911. doi: 10.3389/fonc.2021.705911. eCollection 2021.
3
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
乳腺钼靶密度作为韩国600多万女性浸润性乳腺癌和导管原位癌的预测指标。
Breast Cancer Res Treat. 2025 Jun;211(2):341-350. doi: 10.1007/s10549-025-07648-z. Epub 2025 Feb 28.
4
Height and breast cancer risk in premenopausal Korean women aged under 40 years of age.40岁以下韩国绝经前女性的身高与乳腺癌风险
Br J Cancer. 2024 Dec;131(12):1913-1918. doi: 10.1038/s41416-024-02846-w. Epub 2024 Oct 7.
5
Comprehensive review of drug-mediated ICD inhibition of breast cancer: mechanism, status, and prospects.药物介导的 ICD 抑制乳腺癌的综合综述:机制、现状与展望。
Clin Exp Med. 2024 Sep 26;24(1):230. doi: 10.1007/s10238-024-01482-1.
6
Is there an association between mastitis and breast cancer? a retrospective cohort study from Germany.乳腺炎与乳腺癌之间是否存在关联?来自德国的一项回顾性队列研究。
Cancer Causes Control. 2024 Dec;35(12):1517-1523. doi: 10.1007/s10552-024-01909-w. Epub 2024 Aug 29.
7
Tall women with breast cancer have poorer survival than short women.患有乳腺癌的高个子女性比矮个子女性的生存率更低。
medRxiv. 2024 Jul 9:2024.07.08.24310089. doi: 10.1101/2024.07.08.24310089.
8
Impact of NDUFAF6 on breast cancer prognosis: linking mitochondrial regulation to immune response and PD-L1 expression.NDUFAF6对乳腺癌预后的影响:将线粒体调节与免疫反应及程序性死亡受体配体1(PD-L1)表达相联系
Cancer Cell Int. 2024 Mar 8;24(1):99. doi: 10.1186/s12935-024-03244-1.
9
Is there an association between endometriosis and subsequent breast cancer? A retrospective cohort study from Germany.内异症与后续乳腺癌之间是否存在关联?来自德国的一项回顾性队列研究。
Breast Cancer Res Treat. 2024 Apr;204(2):359-365. doi: 10.1007/s10549-023-07211-8. Epub 2023 Dec 23.
10
Vegan Diets for Children: A Narrative Review of Position Papers Published by Relevant Associations.儿童素食饮食:相关协会发布的立场文件的叙述性综述。
Nutrients. 2023 Nov 7;15(22):4715. doi: 10.3390/nu15224715.
《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
4
Prescription of hormone replacement therapy prior to and after the diagnosis of gynecological cancers in German patients.德国患者妇科癌症诊断前后激素替代疗法的处方。
J Cancer Res Clin Oncol. 2020 Jun;146(6):1567-1573. doi: 10.1007/s00432-020-03185-y. Epub 2020 Mar 18.
5
Incidence of fractures in young women with breast cancer - a retrospective cohort study.年轻乳腺癌女性骨折的发生率——一项回顾性队列研究。
J Bone Oncol. 2019 Jul 26;18:100254. doi: 10.1016/j.jbo.2019.100254. eCollection 2019 Oct.
6
Adult height in relation to risk of cancer in a cohort of 22,809,722 Korean adults.22809722 名韩国成年人队列中与癌症风险相关的成人身高。
Br J Cancer. 2019 Mar;120(6):668-674. doi: 10.1038/s41416-018-0371-8. Epub 2019 Feb 19.
7
Basic characteristics and representativeness of the German Disease Analyzer database
.德国疾病分析器数据库的基本特征及代表性
Int J Clin Pharmacol Ther. 2018 Oct;56(10):459-466. doi: 10.5414/CP203320.
8
Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization.身高与乳腺癌风险:来自前瞻性研究和孟德尔随机化的证据。
J Natl Cancer Inst. 2015 Aug 20;107(11). doi: 10.1093/jnci/djv219. Print 2015 Nov.
9
The role of the insulin-like growth factor-1 system in breast cancer.胰岛素样生长因子-1系统在乳腺癌中的作用。
Mol Cancer. 2015 Feb 15;14:43. doi: 10.1186/s12943-015-0291-7.
10
Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status.根据绝经后雌激素-孕激素使用和激素受体状态,体重指数与乳腺癌风险的关系。
Epidemiol Rev. 2014;36(1):114-36. doi: 10.1093/epirev/mxt010.